FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Engelson Erik T.
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/4/2021 

3. Issuer Name and Ticker or Trading Symbol

Lucira Health, Inc. [LHDX]
(Last)        (First)        (Middle)

1412 62ND STREET
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
President and Chief Executive /
(Street)

EMERYVILLE, CA 94608      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
2/4/2021 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Series B Preferred Stock  (1) (1)Common Stock 48854 (2) (1)I See footnote (3)

Explanation of Responses:
(1) Each share of Series B Preferred Stock (the "Preferred Stock") automatically converts on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock have no expiration date.
(2) These shares were inadvertently omitted from the Reporting Person's original Form 3, and also were omitted from two Forms 4 filed by the Reporting Person after his original Form 3 was filed.
(3) The shares are held by Epic Pacific, LLC, of which Reporting Person is a Member.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Engelson Erik T.
1412 62ND STREET
EMERYVILLE, CA 94608
X
President and Chief Executive

Signatures
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson3/25/2021
**Signature of Reporting PersonDate

Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Lucira Health Charts.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Lucira Health Charts.